ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,856Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 315

$1.02M Total Retail Price of All Prescriptions

Rank: 10 out of 315

483 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 483 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 12,452 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
SIMVASTATIN 830 760 1 1
AMLODIPINE BESYLATE 696 642 2 2
LOSARTAN POTASSIUM 617 580 3 4
ATORVASTATIN CALCIUM 510 434 4 5
JANUVIA 362 329 5 31
METFORMIN HCL 328 295 6 7
OMEPRAZOLE 302 258 7 9
DIOVAN 301 254 8 27
LOVASTATIN 288 249 9 8
LEVOTHYROXINE SODIUM 283 273 10 6
ALENDRONATE SODIUM 270 261 11 12
ALLOPURINOL 236 226 12 14
LISINOPRIL 223 196 13 3
HYDRALAZINE HCL 221 219 14 98
LOVAZA 197 177 15 64
BENICAR 188 182 16 80
ATENOLOL 185 154 17 11
CRESTOR 179 172 18 24
GLIPIZIDE ER 172 144 19 55
FUROSEMIDE 169 133 20 15
CELEBREX 147 142 21 34
AMOXICILLIN 139 123 22 65
AMOX TR-POTASSIUM CLAVULANATE 133 115 23 147
TAMSULOSIN HCL 124 122 24 21
CARVEDILOL 123 110 25 22
CLOPIDOGREL 115 97 26 25
AMLODIPINE BESYLATE-BENAZEPRIL 113 95 27 26
FINASTERIDE 110 95 28 60
HYDROCODONE-ACETAMINOPHEN 109 72 S3 29 19
ADVAIR DISKUS 106 91 30 46
NEXIUM 99 81 31 54
PREDNISONE 99 88 31 41
CLOBETASOL PROPIONATE 97 77 33 82
METOPROLOL SUCCINATE 94 81 34 13
FOLBIC 90 90 35 270
MECLIZINE HCL 87 78 36 81
METOPROLOL TARTRATE 85 85 37 18
CIPROFLOXACIN HCL 84 75 38 58
PRAVASTATIN SODIUM 81 81 39 10
COLCRYS 78 67 40 85
PLAVIX 76 65 41 40
LOSARTAN-HYDROCHLOROTHIAZIDE 74 70 42 17
FELODIPINE ER 72 72 43 23
HYDROCHLOROTHIAZIDE 71 71 44 16
DIOVAN HCT 70 70 45 56
LIDODERM 69 68 46 76
IRBESARTAN 68 63 47 66
ISOSORBIDE MONONITRATE ER 65 65 48 92
VESICARE 63 56 49 150
PANTOPRAZOLE SODIUM 62 62 50 35
DILTIAZEM 24HR ER 62 62 50 90
GLIPIZIDE 61 61 52 30
PROAIR HFA 61 42 52 52
FENOFIBRATE 60 59 54 43
JANUMET 58 52 55 83
LIPITOR 58 56 55 44
MELOXICAM 55 42 57 77
AMLODIPINE-ATORVASTATIN 55 55 57 118
DIGOXIN 54 49 59 45
VERAPAMIL ER 54 47 59 94
WARFARIN SODIUM 54 54 59 20
ULORIC 54 53 59 182
NAMENDA 54 54 59 38
FLUTICASONE PROPIONATE 53 43 64 53
GABAPENTIN 53 41 64 37
GLIPIZIDE XL 51 44 66 122
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.